Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database-Reference-Cited by-同舟云学术

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database

Published:2017-04-26 Issue:1 Volume:9 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

Ben Bouallègue Fayçal^ORCID, ,Mariano-Goulart Denis,Payoux Pierre

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1186/s13195-017-0260-z.pdf

Reference53 articles.

1. Petersen RC, Aisen P, Boeve BF, Geda YE, Ivnik RJ, Knopman DS, et al. Mild cognitive impairment due to Alzheimer disease in the community. Ann Neurol. 2013;74:199–208.

2. Ellendt S, Voß B, Kohn N, Wagels L, Goerlich K, Drexler E, et al. Predicting stability of mild cognitive impairment (MCI): findings of a community based sample. Curr Alzheimer Res. doi: 10.2174/1567205014666161213120807 .

3. Jack Jr CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 2010;9:119–28.

4. Sunderland T, Linker G, Mirza N, Putnam KT, Friedman DL, Kimmel LH, et al. Decreased β-amyloid1–42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA. 2003;289:2094–103.

5. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, et al. Cerebrospinal fluid biomarker signature in Alzheimer’s Disease Neuroimaging Initiative subjects. Ann Neurol. 2009;65:403–13.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights from a 7-Year Dementia Cohort (VALCODIS): ApoE Genotype Evaluation;Journal of Clinical Medicine;2024-08-12

2. A Comparative Analysis of Two Automated Quantification Methods for Regional Cerebral Amyloid Retention: PET-Only and PET-and-MRI-Based Methods;International Journal of Molecular Sciences;2024-07-12

3. Amyloid-PET imaging predicts functional decline in clinically normal individuals;Alzheimer's Research & Therapy;2024-06-17

4. Deep learning-based amyloid PET harmonization to predict cognitive decline in non-demented elderly;Radiology Advances;2024-05-28

5. Contribution of Global Amyloid-PET Imaging for Predicting Future Cognition in the MEMENTO Cohort;Neurology;2024-03-26